Skip to main content
. 2018 Apr 14;8(5):e00930. doi: 10.1002/brb3.930

Table 1.

MR metrics in patients with WD and the healthy controls

SN TH CA GP PU Cerebellum
Left Right Left Right Left Right Left Right Left Right Left Right
FA
WD 0.47 ± 0.20a 0.42 ± 0.15a 0.37 ± 0.15 0.34 ± 0.12a 0.24 ± 0.11 0.28 ± 0.08 0.36 ± 0.14a 0.37 ± 0.11a 0.26 ± 0.15 0.26 ± 0.13 0.35 ± 0.13b 0.30 ± 0.12
Controls 0.63 ± 0.09 0.60 ± 0.09 0.42 ± 0.10 0.42 ± 0.07 0.27 ± 0.10 0.28 ± 0.08 0.50 ± 0.04 0.55 ± 0.03 0.33 ± 0.06 0.35 ± 0.03 0.27 ± 0.13 0.26 ± 0.13
λ1
WD 1.04 ± 0.34 1.01 ± 0.17 0.91 ± 0.25b 1.00 ± 0.33 1.08 ± 0.18 0.99 ± 0.17 0.82 ± 0.21a , b 1.17 ± 0.36a 0.81 ± 0.51a , b 0.95 ± 0.47a 0.79 ± 0.30b 0.81 ± 0.26
Controls 1.23 ± 0.13 1.17 ± 0.08 1.02 ± 0.11 0.92 ± 0.14 1.05 ± 0.07 1.10 ± 0.15 1.18 ± 0.26 1.40 ± 0.09 1.47 ± 0.07 1.38 ± 0.02 0.87 ± 0.13 0.94 ± 0.13
λ2
WD 0.78 ± 0.22 0.73 ± 0.22 0.73 ± 0.14 0.78 ± 0.19 0.82 ± 0.24 0.84 ± 0.17 0.82 ± 0.16a , b 0.98 ± 0.34a 1.14 ± 0.44a 1.04 ± 0.2a 0.62 ± 0.23 0.71 ± 0.27
Controls 0.77 ± 0.14 0.74 ± 0.08 0.74 ± 0.09 0.76 ± 0.13 0.76 ± 0.21 0.88 ± 0.14 0.64 ± 0.12 0.74 ± 0.05 0.72 ± 0.05 0.81 ± 0.05 0.54 ± 0.13 0.65 ± 0.13
λ3
WD 0.51 ± 0.23 0.46 ± 0.22 0.48 ± 0.19 0.53 ± 0.16 0.64 ± 0.17 0.63 ± 0.15 0.56 ± 0.18b 0.65 ± 0.26 0.87 ± 0.35a 0.84 ± 0.22a 0.46 ± 0.25 0.54 ± 0.26
Controls 0.41 ± 0.07 0.46 ± 0.09 0.40 ± 0.11 0.41 ± 0.09 0.65 ± 0.13 0.54 ± 0.13 0.56 ± 0.10 0.57 ± 0.05 0.50 ± 0.07 0.49 ± 0.04 0.48 ± 0.13 0.57 ± 0.13
CP
WD 1,817 ± 47a , b 1,837 ± 52a 2,054 ± 21a , b 2,075 ± 24a 2,024 ± 36a 2,013 ± 41a 1,996 ± 37 1,989 ± 42 2,013 ± 52a 2,009 ± 39a 2,093 ± 27a 2,080 ± 46a
Controls 2,019 ± 77 2,015 ± 63 2,132 ± 32 2,129 ± 41 2,085 ± 45 2,088 ± 62 2,013 ± 69 2,019 ± 52 2,063 ± 23 2,071 ± 51 2,155 ± 19 2,169 ± 21
ALFF
WD 6.81 ± 3.34b 5.51 ± 3.76a 5.05 ± 3.67a 5.25 ± 3.51a 6.70 ± 0.78 6.76 ± 1.08 6.35 ± 0.82a 6.55 ± 1.06a
Controls 7.56 ± 0.50 7.85 ± 0.54 8.22 ± 0.62 8.23 ± 0.65 7.01 ± 0.79 6.98 ± 0.77 7.30 ± 0.81 7.40 ± 0.72
REHO
WD 6.08 ± 3.39a , b 7.27 ± 3.02 6.16 ± 3.34a 6.19 ± 3.41 7.41 ± 0.98 7.23 ± 1.90 7.48 ± 1.86 7.68 ± 1.83
Controls 8.17 ± 0.88 7.87 ± 2.20 8.41 ± 0.73 7.31 ± 2.83 7.77 ± 0.65 7.65 ± 2.17 7.44 ± 2.04 6.72 ± 3.24

ALFF, amplitude of low‐frequency fluctuation; PU, putamen; GP, globus pallidus; CA, head of the caudate nucleus; TH, thalamus; SN, substantia nigra; REHO, regional homogeneity; WD, Wilson's disease.

Results reported as mean±SEM.

a

p ≤ .05 compared with healthy controls.

b

p ≤ .05 compared with the right side.